36Kr's 15min chart shows KDJ Death Cross, bearish Marubozu pattern.
ByAinvest
Wednesday, Oct 8, 2025 12:19 pm ET1min read
KRKR--
The reverse split aims to reduce the total number of outstanding shares from approximately 8.3 million to 0.8 million. Shareholders will receive cash for any fractional shares, with proportionate adjustments made to equity plans. The reverse split was authorized by Movano Health stockholders at the annual meeting held on September 26, 2025 [1].
Geely Auto (00175) has seen its stock rise by over 3% against the market trend, trading at HKD 19.57 with a turnover of HKD 715 million as of press time. The company announced its intention to implement a share repurchase program with an upper limit of HKD 2.3 billion, reflecting a strong capital position and robust financial condition. The funds for the repurchase will come from Geely Auto’s existing capital and cash reserves [2].
Investors should monitor these developments closely, as they may impact the respective companies' stock performance. The reverse stock split for Movano Health may help to stabilize its stock price and meet regulatory requirements, while Geely Auto’s share repurchase program indicates confidence in its business outlook.
MOVE--
According to the 15-minute chart on 36Kr, a KDJ Death Cross and Bearish Marubozu were observed on October 8th at 12:15. This indicates that the momentum of the stock price is shifting towards a downward trend, suggesting a potential further decrease in value. Sellers currently dominate the market, and the bearish momentum is likely to continue.
Movano Health (NASDAQ: MOVE) has announced a 1-for-10 reverse stock split effective October 10, 2025, in an effort to regain compliance with Nasdaq’s minimum bid price requirement. The company’s common stock will continue trading on the Nasdaq Capital Market under the symbol "MOVE" but will begin trading on a split-adjusted basis when markets open on Friday [1].The reverse split aims to reduce the total number of outstanding shares from approximately 8.3 million to 0.8 million. Shareholders will receive cash for any fractional shares, with proportionate adjustments made to equity plans. The reverse split was authorized by Movano Health stockholders at the annual meeting held on September 26, 2025 [1].
Geely Auto (00175) has seen its stock rise by over 3% against the market trend, trading at HKD 19.57 with a turnover of HKD 715 million as of press time. The company announced its intention to implement a share repurchase program with an upper limit of HKD 2.3 billion, reflecting a strong capital position and robust financial condition. The funds for the repurchase will come from Geely Auto’s existing capital and cash reserves [2].
Investors should monitor these developments closely, as they may impact the respective companies' stock performance. The reverse stock split for Movano Health may help to stabilize its stock price and meet regulatory requirements, while Geely Auto’s share repurchase program indicates confidence in its business outlook.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet